142 related articles for article (PubMed ID: 16954466)
1. Realistic rodents? Debate grows over new mouse models of cancer.
Garber K
J Natl Cancer Inst; 2006 Sep; 98(17):1176-8. PubMed ID: 16954466
[No Abstract] [Full Text] [Related]
2. [New approaches in experimental cancerology: in search of therapeutic models].
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
[No Abstract] [Full Text] [Related]
3. [Antitumor drug screening at the National Cancer Institute, U.S.A].
Tsuruo T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2809-15. PubMed ID: 3310904
[TBL] [Abstract][Full Text] [Related]
4. Intellectual property. DuPont ups ante on use of Harvard's OncoMouse.
Marshall E
Science; 2002 May; 296(5571):1212. PubMed ID: 12016275
[No Abstract] [Full Text] [Related]
5. New initiatives aim to test more cancer drugs for children.
Brower V
J Natl Cancer Inst; 2004 Dec; 96(24):1808-10. PubMed ID: 15601634
[No Abstract] [Full Text] [Related]
6. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
7. [Preclinical evaluation of anticancer drugs: a model remaining a model!].
Lavelle F
Bull Cancer; 1998 Oct; 85(10):837-42. PubMed ID: 9835860
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered models have advantages over xenografts for preclinical studies.
Becher OJ; Holland EC
Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
[TBL] [Abstract][Full Text] [Related]
9. Medicine. Building better mouse models for studying cancer.
Marx J
Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
[No Abstract] [Full Text] [Related]
10. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.
Monks A; Scudiero DA; Johnson GS; Paull KD; Sausville EA
Anticancer Drug Des; 1997 Oct; 12(7):533-41. PubMed ID: 9365500
[No Abstract] [Full Text] [Related]
11. Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs.
Frijhoff AF; Conti CJ; Senderowicz AM
Mol Carcinog; 2004 Apr; 39(4):183-94. PubMed ID: 15057870
[TBL] [Abstract][Full Text] [Related]
12. Testing therapeutic potency of anticancer drugs in animal studies: a commentary.
Den Otter W; Steerenberg PA; Van der Laan JW
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):266-72. PubMed ID: 12052010
[TBL] [Abstract][Full Text] [Related]
13. Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity.
Newell DR
Br J Cancer; 2001 May; 84(10):1289-90. PubMed ID: 11355935
[No Abstract] [Full Text] [Related]
14. Laboratory accident kills AIDS mice.
Ezzell C
Nature; 1988 Dec; 336(6200):613. PubMed ID: 3200311
[No Abstract] [Full Text] [Related]
15. The NCI Developmental Therapeutics Program.
Collins JM
Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
[No Abstract] [Full Text] [Related]
16. What's wrong with our cancer models?
Kamb A
Nat Rev Drug Discov; 2005 Feb; 4(2):161-5. PubMed ID: 15688078
[TBL] [Abstract][Full Text] [Related]
17. Mutant Mouse Regional Resource Center Program: a resource for distribution of mouse models for biomedical research.
Grieder FB
Comp Med; 2002 Jun; 52(3):203. PubMed ID: 12102564
[No Abstract] [Full Text] [Related]
18. Chemoinformatic analysis of NCI preclinical tumor data: evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors.
Wallqvist A; Huang R; Covell DG
J Chem Inf Model; 2007; 47(4):1414-27. PubMed ID: 17555311
[TBL] [Abstract][Full Text] [Related]
19. Mouse project to find each gene's role.
Abbott A
Nature; 2010 May; 465(7297):410. PubMed ID: 20505705
[No Abstract] [Full Text] [Related]
20. Pathology of Mouse Models of Human Lung Cancer.
Shmidt EN; Nitkin AY
Comp Med; 2004 Feb; 54(1):23-6. PubMed ID: 15382341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
